Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 2018-02-13 to 2018-04-03
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Version / remarks:
2010
Deviations:
no
GLP compliance:
yes
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
10-methoxy-1,6-dimethylergoline-8β-methanol
EC Number:
252-405-9
EC Name:
10-methoxy-1,6-dimethylergoline-8β-methanol
Cas Number:
35155-28-3
Molecular formula:
C18H24N2O2
IUPAC Name:
10-methoxy-1,6-dimethylergoline-8β-methanol
Specific details on test material used for the study:
Batch No.: 17088R88B
Purity: 97.9%

In vivo test system

Test animals

Species:
mouse
Strain:
CBA:J
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: Young adult animals (approximately 8 weeks old)
- Weight at study initiation: 17.1 to 22.8 g.
- Housing: On arrival and following assignment to the study, animals were group housed (up to 5 animals of the same sex and same dosing group together) in polycarbonate cages containing sterilized sawdust as bedding equipped with water bottles. Animals were separated during designated procedures/activities. Each cage was clearly labeled.
- Diet (e.g. ad libitum): Pelleted rodent diet was provided ad libitum throughout the study, except during designated procedures.
- Water (e.g. ad libitum): Municipal tap-water was freely available to each animal via water bottles.
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): Target temperatures is 18 to 24°C, the actual is 22 °C
- Humidity: Relative target humidity is 40 to 70%, the actucal is 40 to 43%
- Air changes (per hr): Ten or greater air changes per hour with 100% fresh air
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark cycle

Study design: in vivo (LLNA)

Vehicle:
propylene glycol
Concentration:
Pre-screen Test: 25% and 50% w/w
Main Test: 0, 10, 25 and 50 % (w/w)
No. of animals per dose:
Pre-screen Test: two animals per concentration
Main Test: five animals
Details on study design:
PRE-SCREEN TESTS:
- Results: At a 25% and 50% test item concentration, no erythema or signs of toxicity were noted. Variation in ear thickness during the observation period were more than 25% from Day 1 pre-dose values for one ear of one animal at 25% on Day 6. Since the results of the ear thickness measurements were not conclusive, 50% was selected as the highest concentration to be used in the main study and ear thickness measurements were added to the main study.

MAIN STUDY:
- Allocation/concetration: 0, 10, 25 and 50%
- Induction - Days 1, 2 and 3: The dorsal surface of both ears was topically treated (25 µL/ear with the test item, at approximately the same time on each day. The concentrations were stirred with a magnetic stirrer immediately prior to dosing. The control animals were treated in the same way as the experimental animals, except that the vehicle was administered instead of the test item.
- Excision of the Nodes - Day 6: Each animal was injected via the tail vein with 0.25 mL of sterile phosphate buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine. After five hours, all animals were killed by intraperitoneal injection (0.2 mL/animal) of Euthasol® 20%. The draining (auricular) lymph node of each ear was excised. The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in PBS.
-Tissue Processing for Radioactivity - Day 6: Following excision of the nodes, a single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze (maze size: 200 μm, diameter: ± 1.5 cm). LNC were washed twice with an excess of PBS by centrifugation at 200g for 10 minutes at 4ºC. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) and then stored in the refrigerator until the next day.
- Radioactivity Measurements - Day 7: Precipitates were recovered by centrifugation, resuspended in 1 mL TCA and transferred to 10 mL of Ultima Gold cocktail as the scintillation fluid. Radioactivity measurements were performed using a Packard scintillation counter (2800TR). Counting time was to a statistical precision of ± 0.2% or a maximum of 5 minutes whichever came first. The scintillation counter was programmed to automatically subtract background and convert Counts Per Minute (CPM) to Disintegrations Per Minute (DPM).

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Key result
Parameter:
SI
Value:
1.5
Test group / Remarks:
the test item concentrations 10%
Key result
Parameter:
SI
Value:
1.1
Test group / Remarks:
the test item concentrations 25 %
Key result
Parameter:
SI
Value:
1.7
Test group / Remarks:
the test item concentrations 50 %
Cellular proliferation data / Observations:
- Skin Reactions / Irritation:
No irritation was observed in any of the animals.
Beige test item remnants were present on the dorsal surface of the ears of all test item treated animals between Days 1 and 3, which did not hamper scoring of the skin reactions.

- Ear Thickness Measurements:
Variation in ear thickness during the observation period were less than 25% from Day 1 pre-dose values for the majority of animals. The variation slightly exceeded 25% for one animal treated at 25% and three animals treated at 50%. As no clear correlation was seen with the DPM values, these findings were considered not to have affected the results of the study.

- Systemic Toxicity:
No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.

- Macroscopic Examination of the Lymph Nodes and Surrounding Area:
All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size.
No macroscopic abnormalities of the surrounding area were noted for any of the animals.

- Radioactivity Measurements:
Mean DPM/animal values for the experimental groups treated with test item concentrations 10, 25 and 50% were 579, 413 and 659 DPM, respectively. The mean DPM/animal value for the vehicle control group was 383 DPM.

Applicant's summary and conclusion

Interpretation of results:
other: not a skin sensitizer
Conclusions:
Since there was no indication that the test item elicits a SI ≥ 3 when tested up to 50%, the test item was not considered to be a skin sensitizer.
Executive summary:

The objective of this study was to evaluate whether the test item induces skin sensitization in mice (Local Lymph Node Assay) after three epidermal exposures of the animals according to OECD 429. 

In the main study, three experimental groups of five female CBA/J mice were treated with test item concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with the vehicle alone (Propylene glycol). 

No irritation was observed in any of the animals. Variation in ear thickness during the observation period were less than 25% from Day 1 pre-dose values for the majority of animals. The variation slightly exceeded 25% for one animal treated at 25% and three animals treated at 50%. No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.

Mean DPM/animal values for the experimental groups treated with test item concentrations 10, 25 and 50% were 579, 413 and 659 DPM, respectively. The mean DPM/animal value for the vehicle control group was 383 DPM. The SI values calculated for the test item concentrations 10, 25 and 50% were 1.5, 1.1 and 1.7, respectively.

Since there was no indication that the test item elicits a SI ≥ 3 when tested up to 50%, test item was not considered to be a skin sensitizer. It was established that the EC3 value (the estimated test item concentration that will give a SI =3) (if any) exceeds 50%.

Based on these results, test item would not be regarded as a skin sensitizer according to the recommendations made in the test guidelines.